Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data

INTRODUCTION: Triptans, the most commonly prescribed acute treatments for migraine attacks are, per FDA labeling, contraindicated in cardiovascular (CV) disease patients and have warnings and precautions for those with CV risk factors. METHODS: Headache specialists, cardiologists, and health economi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Prim Care Community Health
Autors principals: Dodick, David W., Shewale, Anand S., Lipton, Richard B., Baum, Seth J., Marcus, Steven C., Silberstein, Stephen D., Pavlovic, Jelena M., Bennett, Nathan L., Young, William B., Viswanathan, Hema N., Doshi, Jalpa A., Weintraub, Howard
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7585888/
https://ncbi.nlm.nih.gov/pubmed/33095099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2150132720963680
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars